Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Agonist
30%
Bradykinin
27%
Arachidonic Acid
22%
Ligand
19%
Antagonist
18%
Serotonin
18%
Opiate Receptor
16%
Rat
14%
Heteromer
14%
Drug
13%
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
13%
Desensitization
13%
Protein Kinase C
12%
Adenylate Cyclase
11%
Inverse Agonist
10%
Enkephalin
10%
Inositol Phosphate
10%
Phospholipase A2
8%
Opiate
8%
Functional Selectivity
8%
Pain
7%
Absence
7%
Retina S Antigen
7%
Naloxone
7%
Calcium
7%
Serotonin 2C Receptor
7%
Thermal Allodynia
7%
Chinese Hamster
7%
Norbinaltorphimine
6%
Phospholipase C
6%
Somatomedin C
6%
Mitogen Activated Protein Kinase 3
6%
Receptor Subtype
6%
Dopamine
5%
Phosphotransferase
5%
Proteinase Activated Receptor 2
5%
Delta Opiate Receptor
5%
Insulin
5%
G Protein Coupled Receptor
5%
Forskolin
5%
Drug Development
5%
Neuroscience
Eicosanoid Receptor
69%
Bradykinin
41%
Agonist
33%
Sensory Neuron
27%
δ -Opioid Receptor
21%
5-HT2C Receptor
21%
In Vivo
21%
Arachidonic Acid
19%
Neuron
17%
Serotonin
13%
Opioid
12%
Protein Kinase C
11%
Enkephalin
10%
Ligand
10%
In Vitro
10%
Inverse Agonist
10%
Receptor Agonists
10%
Kappa Opiate Receptor
10%
Phospholipase C
10%
Κ-opioid receptor
9%
Nociceptor
9%
Inositol Phosphate
9%
Cell Signaling
8%
Trigeminal Ganglion
8%
Allodynia
8%
Kinase
7%
Norbinaltorphimine
7%
Brain
7%
Amino Terminal Sequence
7%
Prostaglandin E2
6%
Extracellular Signal-Regulated Kinases
6%
Adenylyl Cyclase
6%
Receptor Subtype
6%
Dopamine Release
6%
Dopamine
6%
Phospholipase A2
6%
5-HT2A Receptor
6%
Functional Selectivity
5%
Inverse Agonism
5%
Medicine and Dentistry
Receptor
70%
Agonist
24%
Ligand
12%
Chemotherapeutic Agent
10%
Drug
10%
Neuron
9%
Cells
9%
Selectivity
9%
Inverse Agonist
9%
Brain
8%
Receptor Subtype
8%
Bradykinin
8%
Therapeutic Procedure
8%
Inositol Phosphate
7%
Inverse Agonism
7%
Signal Transduction
7%
κ-Opioid Receptor
7%
In Vitro
6%
Pain
6%
Regulatory Mechanism
6%
Serotonin
6%
Ganglion
5%
Combination Therapy
5%
Nociceptor
5%
Dopamine
5%
